A Double-Blind, Randomized, Crossover Trial of CSII Reservoir In-use Comparing Insulin Lispro Formulation to Insulin Aspart in Patients With Type 1 Diabetes Mellitus.
Phase of Trial: Phase III
Latest Information Update: 11 Apr 2016
At a glance
- Drugs Insulin lispro (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 29 Mar 2012 Planned number of patients changed from 132 to 180 as reported by European Clinical Trials Database record.
- 19 Dec 2011 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.